Form 4 for LDOS Leidos
Accepted 2022-03-08 00:00:00 ET · period of report 2022-03-04 · accession 0001628280-22-005476 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2022-03-08 | 2022-03-04 | LDOS | Opiekun Deborah D. | Chief Business Development | A - Grant | $0.00 | +2,667 | 2,667 | New | $0 |
| DM | 2022-03-08 | 2022-03-05+ | LDOS | Opiekun Deborah D. | Chief Business Development | F - Tax | $57.04 | -105 | 10.5K | -1.0% | -$5,990 |
| D | 2022-03-08 | 2022-03-04 | LDOS | Opiekun Deborah D. | Chief Business Development | A - Grant | $0.00 | +6,453 | 6,453 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-04 | A | A | 2,666.97 | $0.00 | 2,666.97 | I By Key Executive Stock Deferral Plan | — | — | |
| 2 | Common | Common Stock | 2022-03-06 | F | D | 48 | $0.00 | 10,433.54 | D | — | — | |
| 3 | Common | Common Stock | 2022-03-05 | F | D | 57 | $105.08 | 10,481.54 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-03-04 | A | A | 6,453 | $0.00 | 6,453 | D | $105.08 · 2023-03-04 to 2029-03-03 | 6,453 Common Stock | (F2) The options vest and become exercisable in four equal annual installments beginning on March 4, 2023. |